Evidence map›Paper›PMID 29503094›Full record

ArticleStem cell reports2018

Prospective Isolation of ISL1

Zaniar Ghazizadeh, Faranak Fattahi, Mehdi Mirzaei, Delger Bayersaikhan, Jaesuk Lee, Sehyun Chae, Daehee Hwang, Kyunghee Byun, Mehdi Sharifi Tabar, Sara Taleahmad and 9 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Industrialized GMP Production of CD34Stem cell reviews and reports · 2022
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Spotlight on Isl1: A Key Player in Cardiovascular Development and Diseases.Frontiers in cell and developmental biology · 2021
    Review
  10. The quest of cell surface markers for stem cell therapy.Cellular and molecular life sciences : CMLS · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 4 countries.

Zaniar GhazizadehDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: zghazizadeh@bwh.harvard.edu.
Faranak FattahiDepartment of Molecular Systems Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Banihashem Square, Banihashem Street, Ressalat Highway, Tehran, Iran.
Mehdi MirzaeiDepartment of Chemistry and Biomolecular Sciences, Macquarie University, Sydney, NSW, Australia; Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia; Australian Proteome Analysis Facility, Macquarie University, Sydney, NSW, Australia.
Delger BayersaikhanCenter for Regenerative Medicine, Gachon University, Incheon City, Republic of Korea.
Jaesuk LeeCenter for Regenerative Medicine, Gachon University, Incheon City, Republic of Korea.
Sehyun ChaeDepartment of New Biology and Center for Plant Aging Research, Institute for Basic Science, Daegu Gyeongbuk Institute of Science and Technology, Daegu, Republic of Korea.
Daehee HwangDepartment of New Biology and Center for Plant Aging Research, Institute for Basic Science, Daegu Gyeongbuk Institute of Science and Technology, Daegu, Republic of Korea.
Kyunghee ByunCenter for Regenerative Medicine, Gachon University, Incheon City, Republic of Korea.
Mehdi Sharifi TabarDepartment of Molecular Systems Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Banihashem Square, Banihashem Street, Ressalat Highway, Tehran, Iran.
Sara TaleahmadDepartment of Molecular Systems Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Banihashem Square, Banihashem Street, Ressalat Highway, Tehran, Iran.
Shahab MirshahvaladiDepartment of Molecular Systems Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Banihashem Square, Banihashem Street, Ressalat Highway, Tehran, Iran.
Parisa ShabaniDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Hananeh FonoudiDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Paul A HaynesDepartment of Chemistry and Biomolecular Sciences, Macquarie University, Sydney, NSW, Australia.
Hossein BaharvandDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran; Department of Developmental Biology, University of Science and Culture, ACECR, Tehran, Iran.
Nasser AghdamiDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran; Department of Regenerative Biomedicine at Cell Science Research, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Todd EvansDepartment of Surgery, Weill Cornell Medicine, New York, NY, USA.
Bonghee LeeCenter for Regenerative Medicine, Gachon University, Incheon City, Republic of Korea. Electronic address: bhlee@gachon.ac.kr.
Ghasem Hosseini SalekdehDepartment of Molecular Systems Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Banihashem Square, Banihashem Street, Ressalat Highway, Tehran, Iran; Department of Molecular Sciences, Macquarie University, Sydney, NSW, Australia. Electronic address: salekdeh@royaninstitute.org.
Academic Center for Education, Culture and Research · IRRoyan Institute · IRGachon University · KRDaegu Gyeongbuk Institute of Science and Technology · KRAustralian Genome Research Facility · AUCornell University · USMacquarie University · AU

Funding

A Gata456 Pipeline of DiscoveryR35HL135778 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI EVANS, TODD R · 2017 to 2023
$5.7M
NHLBI NIH HHS R35 HL135778
6 · The paper itself

Abstract

The LIM-homeodomain transcription factor ISL1 marks multipotent cardiac progenitors that give rise to cardiac muscle, endothelium, and smooth muscle cells. ISL1

Indexed as

AnimalsCell DifferentiationCell LineageCells, CulturedEmbryonic Stem CellsEndothelial CellsHumansLIM-Homeodomain ProteinsMaleMiceMyocardial InfarctionMyocardiumMyocytes, CardiacMyocytes, Smooth MuscleProteomicsRatsLIM-Homeodomain ProteinsTranscription Factorscell therapymyocardial biologyproteomicsstem cells

Identifiers

PMID29503094
PMCPMC5918615
OpenAlexW2792749212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.